Concepedia

Xingyi Li

XL

Statistics

Publications

1

Citations

42

H-Index

1

Active since

2021

Affiliations

Harbin Medical University(Current)

Xingyi Li is an author at Harbin Medical University specializing in cancer pharmacology, cancer cell proliferation inhibition, and cell cycle arrest signaling.

ORCID

Publications per year

2021–2021

1

Publications

1

Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway

Yadong Liu, Huiyan Lv, Xingyi Li et al. · International Journal of Biological Sciences · 2021 · 42 citations · Full text

, , +14

1–1 of 1